Variable | COX | |||
---|---|---|---|---|
Univariate analysis | Multivariate analysis | |||
HR (95%CI) | p value | HR (95%CI) | p value | |
RFS | ||||
 Age | 0.983 (0.940–1.028) | 0.457 |  |  |
 Gender | 1.624 (0.487–5.416) | 0.430 |  |  |
 Operative procedure | 1.038 (0.438–2.458) | 0.933 |  |  |
 Operative method | 1.116 (0.523–2.382) | 0.776 |  |  |
 Operative time | 0.998 (0.988–1.009) | 0.722 |  |  |
 Blood loss | 1.000 (0.999–1.002) | 0.673 |  |  |
 Surgical margin | 1.325 (0.617–2.843) | 0.471 |  |  |
 Tumor size | 1.171 (0.996–1.378) | 0.056 |  |  |
 Number of tumors | 2.490 (0.854–7.261) | 0.095 | 3.241 (1.077–9.751) | 0.036 |
 Differentiation | 1.750 (0.800–3.825) | 0.161 |  |  |
 MVI classification | 3.011 (1.396–6.494) | 0.005 | 3.539 (1.631–7.681) | 0.001 |
 Envelope invasion | 2.118 (0.967–4.638) | 0.061 |  |  |
 Fibrosis S score | 1.259 (0.582–2.724) | 0.558 |  |  |
 HBV-Ag | 1.320 (0.397–4.390) | 0.651 |  |  |
 AFP level | 1.544 (0.900–2.650) | 0.115 |  |  |
 Postoperative treatment strategies | 0.337 (0.150–0.759) | 0.009 | 0.286 (0.125–0.651) | 0.003 |
OS | ||||
 Age | 1.011 (0.950–1.077) | 0.724 |  |  |
 Gender | 0.639 (0.178–2.294) | 0.492 |  |  |
 Operative procedure | 1.676 (0.561–5.007) | 0.355 |  |  |
 Operative method | 0.936 (0.325–2.700) | 0.903 |  |  |
 Operative time | 1.002 (0.989–1.016) | 0.743 |  |  |
 Blood loss | 1.001 (0.999–1.003) | 0.312 |  |  |
 Surgical margin | 1.914 (0.663–5.526) | 0.230 |  |  |
 Tumor size | 1.267 (1.056–1.519) | 0.011 | 1.357 (1.105–1.667) | 0.004 |
 Number of tumors | 2.354 (0.524–10.567) | 0.264 |  |  |
 Differentiation | 1.224 (0.424–3.534) | 0.709 |  |  |
 MVI classification | 4.801 (1.601–14.398) | 0.005 | 4.519 (1.460–13.993) | 0.009 |
 Envelope invasion | 1.911 (0.639–5.718) | 0.247 |  |  |
 Fibrosis S score | 2.873 (0.800–10.312) | 0.106 |  |  |
 HBV-Ag | 1.987 (0.260–15.202) | 0.508 |  |  |
 AFP level | 1.650 (0.769–3.540) | 0.199 |  |  |
 Postoperative treatment strategies | 0.204 (0.056–0.737) | 0.015 | 0.094 (0.022–0.397) | 0.001 |